生物化学方法对多种乳酸) -铜复合物 - - 对血液凝固过程的影响
Zdzisława Mrozińska1, Marcin H Kudzin1, Michał B Ponczek2
1Łukasiewicz Research Network-Lodz Institute of Technology, 19/27 Marii Sklodowskiej-Curie Str., 90-570 Lodz, Poland.
Materials (Basel, Switzerland)
|April 9, 2024
概括
这项研究表明,聚乳酸铜复合材料具有显著的抗微生物和抗真菌特性. 在Poly ((Lactide) 织物上的铜也调节了血液凝固,提供了多方面的生物医学应用.
科学领域:
- 生物材料科学 生物材料科学
- 材料科学 材料科学 材料科学
- 微生物学 微生物学
背景情况:
- 聚乳酸 (PLA) 是一种生物相容的聚合物,具有生物医学应用的潜力.
- 开发具有增强生物特性的功能化PLA材料对于先进的医疗器械至关重要.
- 铜的已知抗微生物特性使其成为复合材料开发的候选者.
研究的目的:
- 为了研究Poly (乳酸) -铜复合材料的生物特性.
- 评估复合物的抗微生物和抗真菌功效.
- 为了评估改性PLA的静血性质和血液凝固效应.
主要方法:
- 通过喷雾沉积制造聚乳酸) -铜复合物.
- 对黄金葡萄球菌,大肠杆菌,Pseudomonas aeruginosa,Chaetomium globosum和Candida albicans进行微生物活性测试.
- 生物化学-血液学测试,包括激活的部分血栓形成时间,前血时间,血时间和纤维素网络成像.
主要成果:
- 聚乳酸) - 铜复合物显示出相当大的抗微生物和抗真菌活性.
- 未经修改的Poly ((乳酸) 织物加速了血凝固 (内在途径).
- 在Poly (乳酸) 上涂铜取消了加速凝固的效果.
结论:
- 聚乳酸铜复合材料显示出作为抗菌和抗真菌材料的前景.
- 基于PLA的材料可以定制用于伤口,控制凝血并提供病原体耐药性.
- 用金属修改的PLA提供了可定制的解决方案,用于控制血液静止和抗菌作用.
更多相关视频
10:15The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits
Published on: August 20, 2014
11.6K
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.8K
相关概念视频
01:09Coagulation
6.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.4K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.4K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
689
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
689